Table 1 Clinical and biochemical characteristics of the study population
From: Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease
Variables | CAD | Control | p |
|---|---|---|---|
Sex (M/F) | 168/111 | 180/88 | 0.0913 |
Age (years) | 69.30 ± 0.7049 | 63.73 ±0.6952 | < 0.0001 |
BMI (kg/m2) | 23.18 ±0.1337 | 21.04 ±0.08991 | <0.0001 |
Smoke (%) | 12.19 | 5.60 | 0.007 |
Hypertension (%) | 26.16 | 18.66 | 0.0355 |
DM (%) | 25.81 | 15.30 | 0.0024 |
AF (%) | 8.60 | 0 | < 0.0001 |
Stroke (%) | 7.17 | 1.12 | 0.0004 |
High TC (%) | 10.39 | 8.21 | 0.3796 |
High TG (%) | 13.62 | 7.09 | 0.0125 |
Low HDL (%) | 28.32 | 38.06 | 0.0155 |
High LDL (%) | 10.04 | 9.33 | 0.7798 |
Lp(a) (mg/l) | 265.4 ± 12.43 | 215.9 ± 11.11 | 0.0033 |
BUN (mmol/l) | 5.898 ± 0.1978 | 5.075 ± 0.1675 | 0.0016 |
SUA (μmol/l) | 340.6 ± 6.018 | 280.6 ± 6.629 | < 0.0001 |
Glu (mmol/l) | 6.549 ± 0.1418 | 6.011 ± 0.1231 | 0.0046 |
CHOL (mmol/l) | 4.785 ± 0.07130 | 4.821 ± 0.2581 | 0.8885 |
TG (mmol/l) | 1.567 ± 0.07598 | 1.341 ± 0.04895 | 0.0148 |
HDL (mmol/l) | 1.256 ± 0.0214 | 1.242 ±0.02509 | 0.6613 |
LDL (mmol/l) | 2.854 ± 0.05867 | 4.190 ± 1.467 | 0.3377 |
ApoA1 (g/l) | 1.339 ± 0.02123 | 1.262 ± 0.02484 | 0.0187 |
ApoB (g/l) | 0.9414 ± 0.01682 | 0.8810 ± 0.01690 | 0.0117 |